Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Rath, Timo ^a   Roderfeld, Martin ^a   Blöcher, Sonja ^a   Rhode, Annika ^a   Basler, Tina ^b   Akineden, Ömer ^a   Abdulmawjood, Amir ^a   Halwe, Jörg M ^c,d   Goethe, Ralph ^b   Bülte, Michael ^a   Roeb, Elke ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Veterinarian Medical Academy Hannover   (Germany)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d Stord Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BACTERIAL DNA; COLLAGENASE 3; CORTICOSTEROID DERIVATIVE; GELATINASE A; GELATINASE B; INFLIXIMAB; INTERSTITIAL COLLAGENASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 19; MESALAZINE; PROTEIN MMP 28; RNA 18S; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DNA DETERMINATION; FEMALE; GENE EXPRESSION; GERMANY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM PARATUBERCULOSIS; NORWAY; NUCLEOTIDE SEQUENCE; PREVALENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ANALYSIS; ULCERATIVE COLITIS; BIOPSY; BIOSYNTHESIS; COHORT ANALYSIS; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PARATUBERCULOSIS;

ADULT; AGED; BIOPSY; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DNA, BACTERIAL; FEMALE; GENE EXPRESSION REGULATION; GERMANY; HUMANS; INTESTINAL MUCOSA; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; NORWAY; PARATUBERCULOSIS; YOUNG ADULT;

EID: 79953756685     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-34     Document Type: Article

References (64)

1. Tiwari A, VanLeeuwen JA, McKenna SL, Keefe GP, Barkema HW. Johne's disease in Canada Part I: clinical symptoms, pathophysiology, diagnosis, and prevalence in dairy herds. Can Vet J 2006, 47:874-882. 1555680, 17017652.
2. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009, 361:2066-2078. 10.1056/NEJMra0804647, 19923578.
3. Dalziel TK. Chronical intestinal enteritis. Br Med J 1913, 2:1068-1070.
4. Abubakar I, Myhill D, Aliyu SH, Hunter PR. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis 2008, 14:401-410. 10.1002/ibd.20276, 17886288.
5. Behr MA, Kapur V. The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr Opin Gastroenterol 2008, 24:17-21. 10.1097/MOG.0b013e3282f1dcc4, 18043227.
6. Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, Furrer H, Pfyffer GE, Jemmi T, Baumgartner A, Egger M. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 2007, 7:607-613. 10.1016/S1473-3099(07)70211-6, 17714674.
7. Kirkwood CD, Wagner J, Boniface K, Vaughan J, Michalski WP, Catto-Smith AG, Cameron DJ, Bishop RF. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm Bowel Dis 2009, 15:1643-1655. 10.1002/ibd.20967, 19462429.
8. Chamberlin WM, Naser SA. Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. Med Sci Monit 2006, 12:RA27-33.
9. Mendoza JL, Lana R, Diaz-Rubio M. Mycobacterium avium subspecies paratuberculosis and its relationship with Crohn's disease. World J Gastroenterol 2009, 15:417-422. 10.3748/wjg.15.417, 2653362, 19152445.
10. Clancy R, Ren Z, Turton J, Pang G, Wettstein A. Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-alpha secretion. Dig Liver Dis 2007, 39:445-451. 10.1016/j.dld.2006.12.006, 17317344.
11. Sibartie S, Scully P, Keohane J, O'Neill S, O'Mahony J, O'Hanlon D, Kirwan WO, O'Mahony L, Shanahan F. Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's disease. Inflamm Bowel Dis 2010, 16:296-304.
12. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004, 4:617-629. 10.1038/nri1418, 15286728.
13. Rath T, Roderfeld M, Graf J, Roeb E. [Matrix metalloproteinases in inflammatory bowel disease - from basic research to clinical significance]. Z Gastroenterol 2009, 47:758-769. 10.1055/s-0028-1109520, 19662589.
14. Rath T, Roderfeld M, Halwe JM, Tschuschner A, Roeb E, Graf J. Cellular sources of MMP-7, MMP-13 and MMP-28 in ulcerative colitis. Scand J Gastroenterol 2010, 45:1186-1196. 10.3109/00365521.2010.499961, 20568971.
15. Ravi A, Garg P, Sitaraman SV. Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?. Inflamm Bowel Dis 2007, 13:97-107. 10.1002/ibd.20011, 17206645.
16. Coussens PM, Colvin CJ, Rosa GJ, Perez Laspiur J, Elftman MD. Evidence for a novel gene expression program in peripheral blood mononuclear cells from Mycobacterium avium subsp. paratuberculosis-infected cattle. Infect Immun 2003, 71:6487-6498. 10.1128/IAI.71.11.6487-6498.2003, 219592, 14573671.
17. Coussens PM, Pudrith CB, Skovgaard K, Ren X, Suchyta SP, Stabel JR, Heegaard PM. Johne's disease in cattle is associated with enhanced expression of genes encoding IL-5, GATA-3, tissue inhibitors of matrix metalloproteinases 1 and 2, and factors promoting apoptosis in peripheral blood mononuclear cells. Vet Immunol Immunopathol 2005, 105:221-234. 10.1016/j.vetimm.2005.02.009, 15808302.
18. Quiding-Jarbrink M, Smith DA, Bancroft GJ. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001, 69:5661-5670. 10.1128/IAI.69.9.5661-5670.2001, 98682, 11500442.
19. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317:1625-1629. 10.1056/NEJM198712243172603, 3317057.
20. Schonenbrucher H, Abdulmawjood A, Failing K, Bulte M. New triplex real-time PCR assay for detection of Mycobacterium avium subsp. paratuberculosis in bovine feces. Appl Environ Microbiol 2008, 74:2751-2758. 10.1128/AEM.02534-07, 2394907, 18326682.
21. Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G, Pickup R, Hermon-Taylor J. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol 2003, 41:2915-2923. 10.1128/JCM.41.7.2915-2923.2003, 165291, 12843021.
22. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45. 10.1093/nar/29.9.e45, 55695, 11328886.
23. Chacon O, Bermudez LE, Barletta RG. Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol 2004, 58:329-363. 10.1146/annurev.micro.58.030603.123726, 15487941.
24. Harris NB, Barletta RG. Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine. Clin Microbiol Rev 2001, 14:489-512. 10.1128/CMR.14.3.489-512.2001, 88986, 11432810.
25. Cousins DV, Whittington R, Marsh I, Masters A, Evans RJ, Kluver P. Mycobacteria distenct from Mycobacterium avium subsp. paratuberculosis isolated from the faeces of ruminants possess IS900-like sequences detectable IS900 polymerase chain reaction: implications for diagnosis. Mol Cell Probes 1999, 13:431-442. 10.1006/mcpr.1999.0275, 10657148.
26. Englund S, Bolske G, Johansson KE. An IS900-like sequence found in a Mycobacterium sp. other than Mycobacterium avium subsp. paratuberculosis. FEMS Microbiol Lett 2002, 209:267-271. 10.1111/j.1574-6968.2002.tb11142.x, 12007816.
27. Hoorfar J, Cook N, Malorny B, Wagner M, De Medici D, Abdulmawjood A, Fach P. Diagnostic PCR: making internal amplification control mandatory. Lett Appl Microbiol 2004, 38:79-80. 10.1046/j.1472-765X.2003.01456.x, 14746535.
28. Di Sabatino A, Paccagnini D, Vidali F, Rosu V, Biancheri P, Cossu A, Zanetti S, Corazza GR, Sechi LA. Detection of Mycobacterium avium subsp. paratuberculosis (MAP)-specific IS900 DNA and antibodies against MAP peptides and lysate in the blood of Crohn's disease patients. Inflamm Bowel Dis 2010.
29. Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004, 364:1039-1044. 10.1016/S0140-6736(04)17058-X, 15380962.
30. Baksh FK, Finkelstein SD, Ariyanayagam-Baksh SM, Swalsky PA, Klein EC, Dunn JC. Absence of Mycobacterium avium subsp. paratuberculosis in the microdissected granulomas of Crohn's disease. Mod Pathol 2004, 17:1289-1294. 10.1038/modpathol.3800184, 15154014.
31. Ellingson JL, Cheville JC, Brees D, Miller JM, Cheville NF. Absence of Mycobacterium avium subspecies paratuberculosis components from Crohn's disease intestinal biopsy tissues. Clin Med Res 2003, 1:217-226. 10.3121/cmr.1.3.217, 1069047, 15931311.
32. Freeman H, Noble M. Lack of evidence for Mycobacterium avium subspecies paratuberculosis in Crohn's disease. Inflamm Bowel Dis 2005, 11:782-783. 10.1097/01.MIB.0000179317.27132.24, 16043998.
33. Lozano-Leon A, Barreiro-de Acosta M, Dominguez-Munoz JE. Absence of Mycobacterium avium subspecies paratuberculosis in Crohn's disease patients. Inflamm Bowel Dis 2006, 12:1190-1192. 10.1097/01.mib.0000236931.58793.22, 17119397.
34. Parrish NM, Radcliff RP, Brey BJ, Anderson JL, Clark DL, Koziczkowski JJ, Ko CG, Goldberg ND, Brinker DA, Carlson RA, et al. Absence of mycobacterium avium subsp. paratuberculosis in Crohn's patients. Inflamm Bowel Dis 2009, 15:558-565. 10.1002/ibd.20799, 19058231.
35. Sasikala M, Reddy DN, Pratap N, Sharma SK, Balkumar PR, Sekaran A, Banerjee R, Reddy DB. Absence of Mycobacterium avium ss paratuberculosis-specific IS900 sequence in intestinal biopsy tissues of Indian patients with Crohn's disease. Indian J Gastroenterol 2009, 28:169-174. 10.1007/s12664-009-0068-2, 20107965.
36. Bull TJ, Hermon-Taylor J, Pavlik I, El-Zaatari F, Tizard M. Characterization of IS900 loci in Mycobacterium avium subsp. paratuberculosis and development of multiplex PCR typing. Microbiology 2000, 146(Pt 9):2185-2197.
37. Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2004, 42:1129-1135. 10.1128/JCM.42.3.1129-1135.2004, 356871, 15004064.
38. Collins MT, Lisby G, Moser C, Chicks D, Christensen S, Reichelderfer M, Hoiby N, Harms BA, Thomsen OO, Skibsted U, Binder V. Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol 2000, 38:4373-4381. 87608, 11101567.
39. Juste RA, Elguezabal N, Garrido JM, Pavon A, Geijo MV, Sevilla I, Cabriada JL, Tejada A, Garcia-Campos F, Casado R, et al. On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. PLoS One 2008, 3:e2537. 10.1371/journal.pone.0002537, 2434204, 18596984.
40. Mendoza JL, San-Pedro A, Culebras E, Cies R, Taxonera C, Lana R, Urcelay E, de la Torre F, Picazo JJ, Diaz-Rubio M. High prevalence of viable Mycobacterium avium subspecies paratuberculosis in Crohn's disease. World J Gastroenterol 2010, 16:4558-4563. 10.3748/wjg.v16.i36.4558, 2945487, 20857526.
41. Juste RA, Elguezabal N, Pavon A, Garrido JM, Geijo M, Sevilla I, Cabriada JL, Tejada A, Garcia-Campos F, Casado R, et al. Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls. Int J Infect Dis 2009, 13:247-254. 10.1016/j.ijid.2008.06.034, 18922720.
42. Mishina D, Katsel P, Brown ST, Gilberts EC, Greenstein RJ. On the etiology of Crohn disease. Proc Natl Acad Sci USA 1996, 93:9816-9820. 10.1073/pnas.93.18.9816, 38512, 8790414.
43. Whan LB, Grant IR, Ball HJ, Scott R, Rowe MT. Bactericidal effect of chlorine on Mycobacterium paratuberculosis in drinking water. Lett Appl Microbiol 2001, 33:227-231. 10.1046/j.1472-765x.2001.00987.x, 11555209.
44. Ayele WY, Svastova P, Roubal P, Bartos M, Pavlik I. Mycobacterium avium subspecies paratuberculosis cultured from locally and commercially pasteurized cow's milk in the Czech Republic. Appl Environ Microbiol 2005, 71:1210-1214. 10.1128/AEM.71.3.1210-1214.2005, 1065148, 15746320.
45. Ellingson JL, Anderson JL, Koziczkowski JJ, Radcliff RP, Sloan SJ, Allen SE, Sullivan NM. Detection of viable Mycobacterium avium subsp. paratuberculosis in retail pasteurized whole milk by two culture methods and PCR. J Food Prot 2005, 68:966-972.
46. Grant IR, Hitchings EI, McCartney A, Ferguson F, Rowe MT. Effect of commercial-scale high-temperature, short-time pasteurization on the viability of Mycobacterium paratuberculosis in naturally infected cows' milk. Appl Environ Microbiol 2002, 68:602-607. 10.1128/AEM.68.2.602-607.2002, 126679, 11823197.
47. Greenstein RJ, Su L, Brown ST. On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in culture. Int J Infect Dis 2009, 13:e254-263. 10.1016/j.ijid.2008.10.016, 19303801.
48. Greenstein RJ, Su L, Haroutunian V, Shahidi A, Brown ST. On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. PLoS One 2007, 2:e161. 10.1371/journal.pone.0000161, 1779805, 17252054.
49. Greenstein RJ, Su L, Shahidi A, Brown ST. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. PLoS One 2007, 2:e516. 10.1371/journal.pone.0000516, 1885215, 17565369.
50. Shin SJ, Collins MT. Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro. Antimicrob Agents Chemother 2008, 52:418-426. 10.1128/AAC.00678-07, 2224720, 18070971.
51. Rutgeerts P, D'Haens G, Targan S, Vasiliauskas E, Hanauer SB, Present DH, Mayer L, Van Hogezand RA, Braakman T, DeWoody KL, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology 1999, 117:761-769. 10.1016/S0016-5085(99)70332-X, 10500056.
52. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353:2462-2476. 10.1056/NEJMoa050516, 16339095.
53. Janagama HK, Jeong K, Kapur V, Coussens P, Sreevatsan S. Cytokine responses of bovine macrophages to diverse clinical Mycobacterium avium subspecies paratuberculosis strains. BMC Microbiol 2006, 6:10. 10.1186/1471-2180-6-10, 1382238, 16478544.
54. Graham MF, Willey A, Zhu YN, Yager DR, Sugerman HJ, Diegelmann RF. Corticosteroids repress the interleukin 1 beta-induced secretion of collagenase in human intestinal smooth muscle cells. Gastroenterology 1997, 113:1924-1929. 10.1016/S0016-5085(97)70012-X, 9394732.
55. Kohn EC, Jacobs W, Kim YS, Alessandro R, Stetler-Stevenson WG, Liotta LA. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J Biol Chem 1994, 269:21505-21511.
56. MacNaul KL, Chartrain N, Lark M, Tocci MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 1990, 265:17238-17245.
57. Rath T, Roderfeld M, Graf J, Wagner S, Vehr AK, Dietrich C, Geier A, Roeb E. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?. Inflamm Bowel Dis 2006, 12:1025-1035. 10.1097/01.mib.0000234133.97594.04, 17075343.
58. Arihiro S, Ohtani H, Hiwatashi N, Torii A, Sorsa T, Nagura H. Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease. Histopathology 2001, 39:50-59. 10.1046/j.1365-2559.2001.01142.x, 11454044.
59. Matsuno K, Adachi Y, Yamamoto H, Goto A, Arimura Y, Endo T, Itoh F, Imai K. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J Gastroenterol 2003, 38:348-354. 10.1007/s005350300062, 12743774.
60. Bister VO, Salmela MT, Karjalainen-Lindsberg ML, Uria J, Lohi J, Puolakkainen P, Lopez-Otin C, Saarialho-Kere U. Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig Dis Sci 2004, 49:653-661. 10.1023/B:DDAS.0000026314.12474.17, 15185874.
61. Han YP, Tuan TL, Wu H, Hughes M, Garner WL. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 2001, 114:131-139. 2435089, 11112697.
62. Han YP, Nien YD, Garner WL. Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 2002, 277:27319-27327. 10.1074/jbc.M202842200, 2651824, 12004062.
63. Ferwerda G, Kullberg BJ, de Jong DJ, Girardin SE, Langenberg DM, van Crevel R, Ottenhoff TH, Van der Meer JW, Netea MG. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J Leukoc Biol 2007, 82:1011-1018. 10.1189/jlb.0307147, 17652449.
64. Kojima Y, Kinouchi Y, Takahashi S, Negoro K, Hiwatashi N, Shimosegawa T. Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene. Tissue Antigens 2001, 58:379-384. 10.1034/j.1399-0039.2001.580606.x, 11929588.